The Pharmacological Targets and Clinical Evidence of Natural Products With Anti-hepatic Inflammatory Properties
Inflammation contributes heavily to the pathogenesis of liver fibrosis, cirrhosis, and even hepatocellular carcinoma. Inflammation is probably a promising target for treatment of liver diseases. The natural products are considered as the potential source of new drug discovery and their pharmacologic...
Saved in:
Main Author: | |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_906d2d4c2c534d31804bb04e02b6d2e7 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Jinghua Peng |e author |
700 | 1 | 0 | |a Jinghua Peng |e author |
245 | 0 | 0 | |a The Pharmacological Targets and Clinical Evidence of Natural Products With Anti-hepatic Inflammatory Properties |
260 | |b Frontiers Media S.A., |c 2018-06-01T00:00:00Z. | ||
500 | |a 1663-9812 | ||
500 | |a 10.3389/fphar.2018.00455 | ||
520 | |a Inflammation contributes heavily to the pathogenesis of liver fibrosis, cirrhosis, and even hepatocellular carcinoma. Inflammation is probably a promising target for treatment of liver diseases. The natural products are considered as the potential source of new drug discovery and their pharmacological effects on hepatic inflammation have been widely reported. In this review, the natural products with anti-hepatic inflammatory properties are summarized based on their pharmacological effects and mechanisms, which are related to the suppression on the inflammation mediators including cytokines and chemokines, pattern recognition receptors, the activated transcriptional factors, and the potential regulatory factors. The clinical evidence is also summarized. | ||
546 | |a EN | ||
690 | |a hepatic inflammation | ||
690 | |a cytokine | ||
690 | |a chemokine | ||
690 | |a inflammasome | ||
690 | |a toll like receptor | ||
690 | |a nuclear factor-kappa B | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Frontiers in Pharmacology, Vol 9 (2018) | |
787 | 0 | |n https://www.frontiersin.org/article/10.3389/fphar.2018.00455/full | |
787 | 0 | |n https://doaj.org/toc/1663-9812 | |
856 | 4 | 1 | |u https://doaj.org/article/906d2d4c2c534d31804bb04e02b6d2e7 |z Connect to this object online. |